SUMMARY
SUMMARY

Myotonic dystrophy type 1 (DM1) is a multisystemic genetic disorder caused by a
CTG trinucleotide repeat expansion in the 3′ untranslated region of DMPK gene. Heart dysfunctions occur in nearly 80% of DM1 patients and are the second leading cause of DM1-related deaths. Despite these figures, the mechanisms underlying cardiac-based DM1 phenotypes are unknown. Herein, we report that upregulation of a non-muscle splice isoform of RNA binding protein RBFOX2 in DM1 heart tissue-due to altered splicing factor and microRNA activities-induces cardiac conduction defects in DM1 individuals. Mice engineered to express the non-muscle RBFOX2 isoform in heart via tetracycline-inducible transgenesis, or CRISPR/Cas9-mediated genome editing, reproduced DM1-related cardiac-conduction delay and spontaneous episodes of arrhythmia. Further, by integrating RNA binding with cardiac transcriptome datasets from both DM1 patients and mice expressing the non-muscle RBFOX2 isoform, we identified RBFOX2-driven splicing defects in the voltage-gated sodium and potassium channels, which can alter their electrophysiological properties. Thus, our results uncover a trans-dominant role for an aberrantly expressed RBFOX2 isoform in DM1 cardiac pathogenesis.
INTRODUCTION
DM1 is an autosomal-dominant disorder and the most commonly inherited form of adult onset muscular dystrophy 1, 2 . The disease arises due to an expansion of trinucleotide CTG repeat in the 3'-UTR of DMPK gene [3] [4] [5] , which produces mutant RNAs with long tracts of CUG repeats r (CUG) exp forming stable hairpin loops that aggregate in the nucleus [6] [7] [8] . Although
DMPK is broadly expressed, and the disease affects multiple tissues, the predominant causes of mortality are muscle wasting and sudden cardiac death [9] [10] [11] . More than two-thirds of DM1 individuals experience severe heart dysfunctions including cardiac-conduction delay, fatal sinoatrial and atrioventricular blocks, atrial fibrillation, and ventricular arrhythmias 9, 12, 13 .
Affected individuals often display atrophy of the conduction system as well as fibrofatty infiltration of the myocardium and the Bundle of His. Further, some patients develop dilated cardiomyopathy along with systolic/diastolic dysfunctions 11, 14, 15 .
The two major mechanisms by which r(CUG) exp RNAs cause toxicity and thereby disease pathogenesis are: (i) the accumulated r(CUG) exp RNAs sequester muscleblind-like proteins (MBNL1, MBNL2 and MBNL3) with high affinity, resulting in their depletion and lossof-function [16] [17] [18] ; (ii) r(CUG) exp RNAs activate the protein kinase C pathway and suppress the expression of specific micro (mi)RNAs causing upregulation of CELF1 protein [19] [20] [21] . MBNL and CELF family of RNA binding proteins direct a large number of developmentally-regulated alternative splicing and polyadenylation decisions [22] [23] [24] [25] [26] . Therefore, disruption of their normal activities in DM1 shifts RNA processing of target pre-mRNAs towards fetal patterns [27] [28] [29] [30] [31] , many of which induce key features of the disease [32] [33] [34] [35] . The exact molecular basis for the electrophysiological and cardiac contractility abnormalities in DM1, however, is still undetermined.
Here, we demonstrate that the non-muscle splice isoform of RNA-binding protein FOX2
(RBFOX240) is overexpressed in DM1 human heart tissues, and that this overexpression results from a combination of elevated CELF1 and reduced miRNA activities. Modeling the increase in non-muscle RBFOX240 isoform in mouse hearts was sufficient to trigger DM1-related cardiac conduction defects. By integrating RBFOX2-RNA interactions with cardiac transcriptome datasets-from DM1 patients, CELF1 overexpressing mice, MBNL1 knockouts, and mice expressing the non-muscle RBFOX240 isoform-we identified a unique set of RBFOX240-driven mRNA splicing defects that are dysregulated in the DM1 hearts. Specifically, the RBFOX240 isoform caused missplicing of voltage-gated sodium and potassium channel transcripts directing generation of pro-arrhythmic variants that elicit altered rates of ion transport and electrophysiological channel properties. Thus, upregulation of non-muscle RBFOX240 isoform augments the production of pathogenic ion channel splice variants that may directly contribute to DM1-related cardiac conduction delay and arrhythmogenesis.
RESULTS
Selective upregulation of the non-muscle RBFOX240 isoform in DM1 heart tissue
Considered as master regulators of tissue-specific alternative splicing 36, 37 , RBFOX proteins (RBFOX1, RBFOX2, and RBFOX3) utilize a highly conserved RRM domain to bind (U)GCAUG motifs in pre-mRNAs and control splicing in a position-dependent manner [38] [39] [40] .
Mutations in RBFOX2 gene were identified as a major risk for congenital heart disease [41] [42] [43] ; and essential roles for RBFOX2 were recently demonstrated in pathogenesis of stress-induced hypertrophy, heart failure, and cardiac pathology of diabetes 44, 45 . We have determined that RBFOX2 protein levels are significantly increased in the autopsied heart samples of DM1 patients but not of individuals with a history of arrhythmias caused due to left ventricular tachycardia (Fig. 1A, B) . Parallel examination of RBFOX2 mRNA unexpectedly showed only a modest increase in abundance in DM1 heart tissues ( Supplementary Fig. 1A ).
RBFOX2 gene has a complex architecture comprising multiple promoters and alternative exons ( Supplementary Fig. 1B ), which direct tissue-specific expression of various RBFOX2 isoforms that are functionally distinct in their RNA binding activities, subcellular localization, and interactions with regulatory co-factors
36
. Amongst them, a pair of 43-nucleotide (nt) and 40-nt exons in the c-terminal domain encode the muscle and non-muscle isoforms that are expressed in a mutually exclusive, developmentally regulated, and evolutionarily conserved manner. Interestingly, the 40-nt exon contains three tyrosine residues (Fig. 1C) that promote a higher-order RBFOX2 complex of proteins called the Large assembly of Splicing Regulators (LASR) complex, which enhances RBFOX2's splicing activity 46, 47 . The 43-nt exon lacks these tyrosine residues (Fig. 1C) , and therefore, fails to form the higher-order LASR complex 47 . Both humans and mice predominantly express the 40-nt exon containing RBFOX2 isoform in fetal hearts, which is replaced by the 43-nt exon containing isoform in adult hearts, specifically within cardiomyocytes ( Supplementary Fig. 1C-E) . Strikingly, we noticed a significant splicing shift-from 43-nt to 40-nt exon-within RBFOX2 transcripts in DM1 patient heart samples (DPSI ranging from 12% to 95%), which was not detected in the hearts of individuals diagnosed with non-DM related arrhythmias or heart failure (Fig. 1D, E) . We inspected three other RBFOX2 alternative exons in unaffected fetal, adult, and DM1 heart tissues, however, their splicing pattern was unaltered during development, or in DM1
( Supplementary Fig. 1F ).
To determine if the increase in RBFOX2 protein abundance and change in its splicing were direct effects of the CTG expansion, we transfected HL-1 cardiac cell cultures with plasmids expressing zero (DT0) or 960 CTG repeats (DT960). Similar to DM1 heart tissues, transient transfection of HL-1 cells with the DT960 plasmid led to a significant elevation in RBFOX2 steady-state protein levels and a simultaneous shift in splicing from 43-nt to the 40-nt exon (Fig. 1F-G and Supplementary Fig. 1G ). To explore potential coupling between the increase in RBFOX2 protein and its isoform switch, we redirected Rbfox2 splicing in HL-1 cells using splice-site (ss) blocking anti-sense oligonucleotides (ASO) 48 . Relative to control, HL-1 cells treated with ASO targeting the 5'ss of 43-nt exon caused a near complete switch to the 40-nt containing isoform but had little effect on RBFOX2 protein abundance (Fig. 1H-I ). These data indicate that increase in RBFOX2 and its splice isoform switch in DM1 are two separate events, and that upregulation of RBFOX2 protein is not a consequence of higher stability of the non-muscle isoform.
Reduced expression of miRNAs de-represses RBFOX2 in DM1 cardiac cultures
Given that RBFOX2 protein levels decrease during postnatal heart development 23 and the decrease is quickly reversed upon Dicer deletion in the adult myocardium 21 , we reasoned that RBFOX2 upregulation in DM1 might result from miRNA deregulation 20, 49, 50 . Consistent with this notion, we found conserved binding sites for a set of miRNAs-Let-7g/7b, miR-135a, miR-9, and miR-186-within the 3'-UTR of Rbfox2 ( Fig. 2A) , and expression of these miRNAs is reduced in DM1 heart tissue 20 . Transient expression of r(CUG) 960 RNA was sufficient to downregulate all five miRNAs in HL-1 cells (Fig. 2B) ; and likewise, transfections with Let-7g, miR-186, Let-7b, miR-9, and miR-135a mimics reduced RBFOX2 protein abundance compared to scrambled control or the non-targeting miR-30 mimic (Fig. 2C) , without affecting Rbfox2 mRNA levels ( Supplementary Fig. 2A ).
To identify which of these miRNAs regulate RBFOX2 through direct interactions, we constructed dual luciferase reporters 51 wherein the 3'-UTR of Rbfox2 was cloned downstream from Renilla luciferase ORF, with or without mutations in seed sequences that would disrupt the predicted miRNA interactions (Supplementary Fig. 2B ). Co-transfection of HEK293T cells with the reporter plasmids and miRNA mimic(s) individually or in combination revealed that relative to control, Let-7g, miR-9, and miR-135a could each repress the luciferase (Rluc/Fluc) activity of wildtype, but not the mutant constructs (Fig. 2D) . Despite lowering RBFOX2 protein levels, miR-186, did not alter the reporter activity (Fig. 2C, D) . We next asked whether restoring the activity of select miRNAs can normalize RBFOX2 levels in a DM1 cardiac cell culture model. Owing to the reduction of Rbfox2 targeting miRNAs, co-transfection of HL-1 cells with DT960, relative to DT0 plasmid, increased the Rbfox2 3'-UTR luciferase reporter activity (Fig. 2B, E) . Notably, supplementing the r(CUG) 960 RNA expressing HL-1 cells with a cocktail of Let-7g, miR-9 and miR-135a mimics normalized not only the reporter activity ( Fig.   2E ) but also endogenous RBFOX2 protein levels (Fig. 2F) . Rbfox2 mRNA levels were unchanged in these experiments (Supplementary Fig. 2C ). Altogether, these findings illustrate that multiple miRNAs directly or indirectly repress RBFOX2 protein expression in cardiac cells, their downregulation de-represses RBFOX2 in DM1 heart, and when supplemented, a mixture of miRNA mimics can reverse this de-repression in a DM1 cardiac cell culture model.
CELF1 upregulation promotes the production of RBFOX240 isoform in the heart
We next sought to address the mechanism(s) promoting generation of RBFOX240 splice isoform in DM1. Because DMPK RNAs containing r(CUG) exp repeats disrupt alternative splicing through MBNL sequestration and/or CELF1 upregulation, we assessed Rbfox2 splicing pattern in the hearts of Mbnl1
, tetracycline (tet)-inducible TRE-CELF1; MHCrtTA, and littermate control mice 23, 27 . Although CELF1 overexpression in the adult heart did not perturb RBFOX2 protein abundance ( Supplementary Fig. 3A ), it evoked a significant shift from 43-nt to 40-nt exon within Rbfox2 transcripts, mimicking the splicing pattern observed in DM1 heart tissue (Fig. 3A, B) . Deletion of MBNL1 had no effect on Rbfox2 splicing. We analyzed published time-series RNA-seq data following CELF1 overexpression in mouse hearts 25 and found a progressive shift in Rbfox2 splicing, which was detected as early as 24h after CELF1 induction (Fig. 3C) . Furthermore, forced expression of CELF1 in HL-1 cells was sufficient to induce a switch from 43-nt to 40-nt exon without affecting RBFOX2 protein levels (Fig. 3D, E and Supplementary Fig. 3B ). As expected, r(CUG) 960 RNA expression resulted in CELF1 upregulation, and a consequent shift in Rbfox2 splicing in these cells (Fig. 3F, G) . To determine whether increased CELF1 levels were required to generate the RBFOX240 isoform in DM1, we used siRNA(s) to offset CELF1 upregulation in r(CUG) 960 RNA expressing HL-1 cells. Relative to scrambled control, Celf1-targeting siRNAs normalized the CELF1 protein levels and partially abrogated the r(CUG) 960 RNA-induced switch in Rbfox2 splicing (Fig. 3F,   G ). These data imply that CELF1 promotes the production of non-muscle RBFOX240 isoform in the heart, and that high CELF1 activity is in part required for producing this isoform in a DM1 cardiac cell culture model.
RBFOX240 isoform induces DM1-like cardiac pathology in mice
Next, we characterized the functional consequences of RBFOX240 isoform in DM1 cardiac pathogenesis. To distinguish the effects of overexpression from splice isoform switch, we generated two separate mice models: a tet-inducible transgenic mouse model that overexpresses FLAG-tagged RBFOX240 isoform in the adult heart; and a CRISPR/Cas9
derived Rbfox2 43-nt exon deletion mouse model ( Supplementary Fig. 4A-D Fig. 4E, F) .
Strikingly, ~20% of TRE-RBFOX240; MHCrtTA bitransgenic mice died within two to three weeks of transgene expression whereas no mortality was seen in Rbfox2 D43/D43 or littermate control mice (Fig. 4E) . Because no apparent differences in heart-to-body weight ratios, atrial and ventricular size or histological abnormalities such as myofiber disarray, inflammation, and fibrosis were evident ( Supplementary Fig. 4G-I ), we suspected that sudden death following RBFOX240 overexpression in the heart might be related to electrical phenotypes. Hence, we performed ECG telemetry on un-anaesthetized TRE-RBFOX240; MHCrtTA bitransgenic micecontinuously recording their ECG waveforms-before (for 48h) and after (for nine days) of Dox administration. In addition, we also did surface ECGs on a separate cohort of wildtype,
Rbfox2
D43/D43
, TRE-RBFOX240; MHCrtTA bitransgenics and littermate control mice following three days of Dox administration.
Compared to the baseline recordings, all mice following overexpression of RBFOX240 isoform exhibited a significant increase in PR interval, indicating slowed conduction from the atria to the ventricles and prolonged QT intervals, indicating prolonged ventricular repolarization ( Fig. 4F and Supplementary Fig. 5A, B) . Importantly, while the uninduced mice displayed a normal sinus rhythm, progressive increases in the number of pauses and arrhythmic events were detected following RBFOX240 overexpression. Heart rate variability and sinus pauses indicated sinus node dysfunction, sometimes resulting in ventricular escape beats. Additionally, we observed premature ventricular contractions and frequent atrioventricular conduction blocks-evidenced by non-conducting P-waves (Fig. 4G) .
Furthermore, nine days after transgene induction, RBFOX240 overexpressing mice showed a high variability in RR interval duration ( Supplementary Fig. 5C ). Echocardiography studies revealed that abnormal conductivity in these mice is accompanied by reduced ejection fraction, fractional shortening and systolic/diastolic alterations ( Supplementary Fig. 5D ). Thus, overexpression of RBFOX240 isoform in mouse heart recapitulates DM1 cardiac phenotypes including conduction delay, spontaneous episodes of arrhythmias and contractile dysfunctions.
Although the electrophysiological defects in Rbfox2 D43/D43 mice were milder relative to RBFOX240 overexpressing mice, ECG analysis of Rbfox2 D43/D43 mice reproduced certain pathologic features of DM1. For instance, we noted a clear trend of prolonged PR interval with narrower QRS morphology in Rbfox2 D43/D43 mice (Fig. 4H) , which reflects supraventricular origin of QRS complex, and suggests that arrhythmias in these mice originate above or within the bundle of His. The slow conductivity was also accompanied by an increase in sinus pauses, atrioventricular blocks and ventricular electric events (Fig. 4I) . Histological and echocardiography studies, however, showed no differences in the systolic/diastolic ventricular dimensions or contractility including fractional shortening between Rbfox2 D43/D43 and wildtype mice ( Supplementary Fig. 4I, 5D ). Collectively, these results demonstrate that inappropriate expression of the non-muscle RBFOX240 isoform in mouse heart disrupts the cardiac conduction, rhythm and function; and analogous to DM1 patients, triggers progressive heart blocks and sudden death in a subset of mice.
RBFOX240 isoform driven transcriptome alterations in DM1 heart tissue
To further investigate the mechanism(s) by which RBFOX240 isoform provokes DM1-like cardiac pathology, we deep-sequenced poly(A) selected RNAs prepared freshly from the ventricular cardiomyocytes isolated from Dox-induced TRE-RBFOX240; MHCrtTA and littermate control mice (Supplementary Table 2 Consistent with earlier studies 39, 40 , the RBFOX2 binding motif GCAUG was significantly overrepresented in the exonic and surrounding intronic regions of RBFOX240-regulated exons (Fig. 5B) . We next integrated the RBFOX240 overexpression RNA-seq data with previously published RBFOX240 iCLIP data from mouse brain 46 . Overlay of these two datasets revealed that ~50% of misspliced pre-mRNAs had a robust RBFOX2-binding cluster in the regulated exon or surrounding introns, but only half of those clusters contained a GCAUG motif (Fig. 5C ).
Because the RBFOX240 isoform in LASR complex can be recruited to RNA directly or indirectly through binding of hnRNP proteins 47 , we searched for pentamers near RBFOX240-iCLIP crosslink sites bearing a GCAUG motif, or not ( Supplementary Fig. 6E, F) . Besides the expected overrepresentation of GCAUG sequences, a clear enrichment of potential hnRNP Mbinding motif UGUGU was noted directly next to the GCAUG containing crosslink sites ( Fig.   5D and Supplementary Fig. 6E ). On the contrary, the polyU-rich hnRNP C-binding motifs were the most enriched pentamers detected adjacent to non-GCAUG containing crosslink sites ( Fig. 5E and Supplementary Fig. 6F ). Thus, our cardiomyocyte data are in agreement with previous studies 46, 47 , that in addition to direct interactions, the non-muscle RBFOX240 isoform can target pre-mRNAs through RNA contacts of hnRNP M and C components of the LASR complex.
To determine the respective contribution of RBFOX240 overexpression towards DM1-in relation to misregulation of MBNL and CELF proteins-we analyzed published cardiac transcriptomes of DM1 patients 52 , CELF1 overexpressing and Mbnl1 DE3/DE3 mice 25 , and compared them with the cardiac transcriptome of RBFOX240 overexpressing mice. Amongst the three mice models, RBFOX240 overexpression reproduced the highest mRNA abundance and splicing defects observed in heart tissue of DM1 patients (Fig. 5F, G) . A large proportion of these mRNA abundance (74%) and splicing (67%) defects were shared in directionality (Fig.   5H) ; however, relative to DM1 hearts, the overall magnitude of change was higher in RBFOX240 overexpressing mouse cardiomyocytes (Fig. 5I ). For the coregulated sets of splicing events, we found a positive correlation of CELF1 with RBFOX240 and a negative correlation of MBNL1 with CELF1 and RBFOX240 proteins ( Supplementary Fig. 6G ). Thus, our analysis confirmed the antagonistic splicing regulation by CELF1 and MBNL1 proteins 23, 25 while revealing a synergistic mode of regulation between RBFOX240 and CELF1 proteins. The involvement of RBFOX240 in DM1 cardiac pathology was further strengthened by the large overlap of gene ontologies between DM1 patients and RBFOX240 overexpressing mice (Fig.   5J ). Altogether, our comparative transcriptomic findings illustrate that upregulation of non-muscle RBFOX240 isoform in DM1 alters the mRNA abundance and splicing of a large group of genes via direct and/or indirect pre-mRNA interactions through the LASR complex.
Structure-function analysis of DM1-associated alternatively spliced isoforms of voltagegated ion channels
Further analysis of the RBFOX240-driven splicing alterations in DM1 identified twentytwo genes encoding components of conduction system and/or contractile apparatus-many of which are related to the NCBI MeSH terms: "Ventricular Tachycardia," "Brugada and Long QT Syndromes," "Atrial Fibrillation" and "Sudden Cardiac Death" (Fig. 6A ). Of these, we elected to focus on SCN5A, CACNA1C, and KCND3 because they encode the major voltage-gated sodium, calcium, and potassium channels in the heart respectively; and they switch to producing their pro-arrhythmic splice isoforms 52-55 in DM1 patients. Additionally, multiple genome-wide association studies have identified variants of SCN5A and KCND3 among genetic determinants of prolonged PR interval and QRS duration 56, 57 , which are distinctive features of cardiac-conduction delay in DM1 patients.
For each cardiac cycle, when the pacemaker cells in the sinoatrial node fire, the action potential spreads through the atrial and ventricular myocardium via gap junctions that allow it to propagate along the myocytes. Once the action potential arrives, activation the membrane potential of myocytes increases, which activates the voltage-gated SCN5A sodium channels (NaV1.5) to mediate a rapid influx of Na + ions (INa) across the cell membrane, resulting in a fast depolarization phase 58 (Fig. 6B) . As the membrane potential continues to increase, the voltage-gated L-type CACNA1C calcium channels (CaV1.2) open, and Ca 2+ ions flow into the cells as an inward current (ICa), causing additional release of Ca 2+ from the sarcoplasmic reticulum, which is crucial for coupling the electrical excitation to the physical contraction of the myocyte 59 (Fig. 6B) . After the membrane potential peaks, the voltage-gated KCND3 potassium channels (KV4.3) open and potassium ions flow out of the cells generating a rapidly inactivating transient outward current (Ito), which is important for the eventual repolarization of cardiac myocytes 60 (Fig. 6B) . Thus, proper impulse propagation and duration of the action potential in heart is highly contingent on the precise function of these ion channels.
Structurally, the voltage-gated ion channels are made up of either four separate subunits (K + channels) or one polypeptide with four homologous domains (Na + and Ca 2+ channels) (Fig. 6C-E) . Each subunit or domain has six transmembrane segments (S1-S6) and a pore loop. The voltage sensing transmembrane element in SCN5A lies within segments S3
and S4, and that of domain I is encoded by a pair of conserved, developmentally regulated, mutually exclusive exons that are each 93-nts long. The fetal exon 6A differs from the adult exon 6B by 31-nts creating seven amino acid substitutions in Nav1.5 protein
61
, which includes replacement of a positively charged lysine (K211) in exon 6A with a negatively charged aspartate (D211) in exon 6B (Fig. 6C) . Because a shift from exon 6B to 6A is linked to DM1-associated cardiac-conduction delay and heart arrhythmias 52,54
, we investigated functionally relevant structural and dynamical differences between the two alternatively spliced Nav1.5 isoforms using molecular dynamics (MD) simulations. Given that the three-dimensional structure of Nav1.5 channel is unavailable, we built homology models of the exon 6A or exon 6B containing human Nav1.5 isoforms using existing structures of the activated sodium channels Nav1.4 and NavPas 62, 63 . These models were then used in subsequent MD simulations, where three independent 100ns-long equilibrium simulations were carried out on 6A or 6B containing Nav1.5 isoforms. In all simulations, the channels were embedded in a lipid bilayer composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) (Fig. 6F) .
Our simulations revealed that in both channels, the S4 helix of domain I largely maintains its a-helical secondary structure (Fig. 6G) , but with different tendencies to form a more tightly wound, longer, and thinner 310-helix at different segments of S4. Analysis of structural dynamics during the simulations showed that, while similar propensities for 310-helix formation were evident in the middle of S4 helix for both 6A and 6B isoforms, the former exhibited a higher 310-helix content near the top portion of S4, which can facilitate the downward S4 transition from the activated (up) state 64 (Fig. 6G, H) . Frequent transitions observed between a-and 310-helix further indicate that the activated state of S4 in the 6A
isoform is destabilized and it may deactivate more readily due to a reduction in energy barrier, which is consistent with a depolarized shift in the voltage-dependence of channel activation for the pro-arrhythmic 6A isoform 52, 54 . Additionally, we note that although D211 in 6B and K211 in 6A are both positioned close to the lipid headgroups, unlike D211, which preferably interacts with the choline moiety at a slightly higher position with respect to the lipid bilayer, K211-due to its longer side-chain-can reach down into the headgroup region and coordinate closely with the nearby phosphate group of POPC lipids (Fig. 6H, Supplementary Fig. 7 ). The K211D variant shifts the voltage-dependence of activation of the 6A containing Nav1.5 isoform back towards the hyperpolarized direction 65 . We propose that the observed persistent lipidinteraction of K211 in 6A isoform is crucial for stabilizing a 310-helical conformation near the top portion of S4 to allow rapid deactivation that would slow the activation kinetics (Supplementary video 1, 2) . Indeed, forced expression of the exon 6A containing NaV1.5 isoform in adult mouse heart reduces excitability, slows conduction velocity, prolongs PR and QRS intervals, and increases susceptibility to arrhythmias 52, 54 .
The primary cardiac isoform of the a1C subunit of L-type calcium channel CACNA1C (CaV1.2) includes a 33-nt alternative exon that increases the length of the linker separating the S3 and S4 segments of domain IV 66 (Fig. 6D) . Likewise, the cardiac isoform of the a subunit of potassium channel KCND3 (KV4.3) includes a 57-nt alternative exon, which encodes 19 amino acids at the C-terminal end (Fig. 6E ).
Amongst these amino acids is a conserved threonine residue, which is phosphorylated by protein kinase C to facilitate regulation of transient outward current Ito Fig. 8A ).
We noticed that Scn5a and Kcnd3 were also misspliced in the hearts of Rbfox2 D43/D43 mice, albeit to a lesser extent (Fig. 7A) , which might explain their milder arrhythmia phenotypes compared to RBFOX240 overexpressing mice. Whereas the 33-nt exon in CACNA1C transcripts was predominantly skipped in DM1 patients, it was not skipped in the RBFOX240 overexpressing or Rbfox2 D43/D43 mice (Fig. 7A) , indicating that the non-muscle RBFOX240 isoform directly binds these intronic regions and, when expressed at high levels, causes skipping of the downstream exon (Fig. 7B) . As expected, no RBFOX240 binding on the Scn5a transcript was detected in the brain iCLIP dataset because Scn5a is a cardiac-specific sodium channel and is not expressed in the brain (Fig. 7B and Supplementary Fig. 8B, C) .
To further investigate whether missplicing of ion channels following RBFOX240
overexpression can be reversed, we first induced TRE-RBFOX240; MHCrtTA mice with Dox for 24h and then silenced the transgene in a subset of mice by withdrawing Dox for a period of 3 days. In the induced mice, expression of RBFOX240 non-muscle isoform was rapidly increased Fig. 8D, E) leading to a switch from exon 6B to 6A in Scn5a and skipping of the 57-nt exon in Kcnd3 transcripts (Fig. 7C) . Turning off the transgene led to a marked reduction in RBFOX240 levels ( Supplementary Fig. 8D, E) , and near-complete restoration of both Scn5a and Kcnd3 splicing to their normal patterns (Fig. 7C) .
(Supplementary
Overall, these data demonstrate that the non-muscle RBFOX240 isoform directs the production of pro-arrhythmic splice variants of sodium and potassium channels that elicit altered activation-deactivation kinetics, rates of ion transport, and electrophysiological properties. Furthermore, quick reversal of ion channel missplicing upon silencing of RBFOX240 transgene suggests that eliminating the aberrant RBFOX240 isoform from heart might mitigate the DM1 cardiac phenotypes.
DISCUSSION
Cardiac arrhythmias are a prominent cause of mortality in DM1 patients [9] [10] [11] ; but, our understanding of the molecular events triggering electrophysiological abnormalities in DM1 heart is limited. In this study, we provide multiple lines of evidence that inappropriate expression of non-muscle RBFOX240 isoform in DM1 heart leads to cardiac conduction delay, atrioventricular heart blocks, and spontaneous arrhythmogenesis. RBFOX family represents a multifunctional group of sequence-specific RNA binding proteins that are critical regulators of splicing in multiple tissues including skeletal muscle, heart, and brain 23, 36, 37, 40, 44, [70] [71] [72] [73] . Loss-offunction mutations in RBFOX2 gene have been associated with congenital heart disease in humans [41] [42] [43] ; whereas RBFOX2 activity in diabetic hearts is inhibited due to upregulation of its dominant negative splice isoform 45, 74 . Recently, RBFOX1 and RBFOX2 proteins were shown to compete with MBNL1 for binding to expanded r(CCUG) exp repeats in DM2 but not to r(CUG) exp repeats in DM1 muscle cells 75 . However, unlike MBNL family of proteins, RBFOX binding to the r(CCUG) exp repeats does not result in sequestration or loss of splicing activity 75 .
We demonstrate that in DM1 patient hearts, levels of a highly active non-muscle RBFOX240 splice isoform are elevated. Our data support a model where combined effects of increased CELF1 activity 19 and reduced expression of specific miRNAs 20 allow for selective upregulation of RBFOX240 isoform in DM1 heart tissue (Fig. 7D) . We further propose that compared to the muscle isoform, RBFOX240 stimulates the higher-order assembly of LASR complex 46, 47 , which boosts its splicing activity, resulting in altered isoform expression of proteins that can disrupt the normal cardiac rhythm and function. Indeed, we demonstrated that RBFOX240 promotes the generation of pathogenic splice variants of voltage-gated sodium and potassium channels that are known to exhibit slower conduction velocity and increased susceptibility to arrhythmias 52,54, 68, 69 . Our MD simulations showed that a RBFOX240-mediated splicing switch in Nav1.5 transcript changes the amino acid composition of the voltage sensing element within domain I that promotes persistent lipid-interactions and stabilizes the 310-helical conformation of S4 helix, which reduces the energy barrier and allows for rapid deactivation of the channel. Accordingly, we found that tet-inducible RBFOX240 overexpression or targeted deletion of the 43-nt muscle-specific exon in Rbfox2 gene results in prolonged PR and QT intervals, inadvertent sinus pauses, atrioventricular heart blocks, and sudden death in mice.
Notably, in a recent large-scale transcriptome study of human DM1 patients, RBFOX2 mRNA levels were inversely correlated with the strength of tibialis muscle 76 . In the future, it would be interesting to determine whether increased RBFOX2 mRNA abundance in DM1 skeletal muscle also accompanies a corresponding splicing switch and whether the non-muscle RBFOX240 isoform acts as a disease modifier in skeletal muscle as well.
The RNA toxicity hypothesis for DM1 predicts that longer CUG repeats will lead to greater sequestration of MBNL proteins, resulting in increased severity of the disease.
Although the severity tends to rise with repeat length, extreme variability in penetrance of specific symptoms is observed across DM1 patient population 2 . For instance, cardiac involvement is reported in more than 80% of individuals, and conduction abnormalities can cause up to 30% of DM1 fatalities 9,10,13
. However, which patients have the highest risk for sudden cardiac death and what molecular events dictate these outcomes are currently unknown. Previous studies have indicated that high NKX2-5 and PKC activities can modify DM1-associated RNA toxicity in the heart 77, 78 . In our study, we noticed that RBFOX240 isoform levels varied considerably among the hearts of DM1 patients. Whether the degree of RBFOX240 upregulation depends on the size of CTG repeat expansion and/or if a threshold for RBFOX240 levels exists that increases the susceptibility of DM1 patients to cardiac arrhythmias remain topics for future investigations. Nonetheless, the fact that normal splicing patterns for both sodium and potassium channels could be restored within days of silencing the RBFOX240 expression highlights the potential of RBFOX240 isoform as a therapeutic target and a biomarker for DM1 cardiac pathology.
DATA AVAILABILITY
All raw RNA-seq data files are available for download from NCBI Gene Expression Omnibus 
